Contrary to leptin, circulating adiponectin levels are decreased in obesity and are inversely correlated with the body mass index (BMI), glycaemia, and circulating insulin levels, as well as with the risk of developing T2DM, obesity, and CVDs [201,202]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.